Cusuan Disai Misong (醋酸地塞米松)醋酸地塞米松

This is a medicine registration record from NMPA data.本页为国家药监局药品注册记录。

Labeled sections from the recorded Chinese source are included below. English wording is a reference translation when one is on file, not an official English label.本记录未接入产品级适应症/安全性标注字段。

生产企业Manufacturer

主要成分Active Ingredients

药物知识说明

地塞米松是一种在国家药监局注册认定的药品。该药品含有地塞米松、樟脑毫克、薄荷脑毫克-84b7d184等成分。

该药品关联的活性成分包括:地塞米松Disai Misong、樟脑毫克、薄荷脑毫克。这些成分信息来自国家药监局数据库。

该药品标注的生产企业为:天津天药药业股份有限公司Chinese legal name: 天津天药药业股份有限公司。

您可以探索含有相同成分的其他药品:地塞米松-a4207ab1成分药品。

本页面内容来自国家药监局数据库,MedicineGraph在此基础上提供关系图谱和知识导航。

Medicine Knowledge

This medicine (original name: 醋酸地塞米松) is a medicine registered with the national drug regulatory authority. It contains recorded ingredients as active ingredient(s).

Active ingredients associated with this product: 地塞米松Disai Misong.

Manufacturers recorded for this product: 天津天药药业股份有限公司Chinese legal name: 天津天药药业股份有限公司.

Explore other medicines containing the same ingredient: 地塞米松 productsProducts containing this recorded ingredient.

Source: MedicineGraph authoritative database. Relationships derived from registered product information.

这是什么What is this

  • 通用名/品名Recorded product name: 醋酸地塞米松Recorded Chinese name: 醋酸地塞米松
  • 规格Specification: ----

本段仅展示注册/说明书已记录的身份属性,不含适应症或用法建议。Identity attributes from registration/leaflet records only; no indications or usage advice.

主要成分Ingredients

生产企业Manufacturer

  • 天津天药药业股份有限公司Chinese legal name: 天津天药药业股份有限公司

注册信息NMPA approval number

  • 批准文号NMPA approval number: 国药准字H12020195

信息来源Source and scope

国家药品监督管理局(中国)药品注册数据及已接入说明书字段。National Medical Products Administration (China) medicine-registration data and linked leaflet fields.

  • 品名来源Name source: 10多万条药品说明书数据库 (HIGH)Package-insert database (more than 100,000 records) (HIGH)
  • 生产企业来源Manufacturer source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)

范围:当前 MedicineGraph 注册记录及已记录的精确关系;非完整目录,亦不构成疗效等同主张,也不支持换用判断。不含适应症/安全性推断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence. No inferred indications/safety.

本段为已核准说明书原文摘录(非改写、非AI摘要),非正式英文标签,亦不构成用药建议。 Not an official English label and not medical advice. English wording, when shown, is a reference translation of the Chinese source label.

English translation for reference. Translated from the Chinese source label. Not an official English label and not medical advice.

NMPA approval number

国药准字H12020195

Manufacturer

Chinese legal name: 天津天药药业股份有限公司 (domestically manufactured)

Indications

English translation unavailable. The original Chinese source label remains available below.

Dosage and administration

English translation unavailable. The original Chinese source label remains available below.

Adverse reactions

English translation unavailable. The original Chinese source label remains available below.

Contraindications

English translation unavailable. The original Chinese source label remains available below.

Precautions

English translation unavailable. The original Chinese source label remains available below.

Storage

Protect from light and keep tightly closed.

Specification

English translation unavailable. The original Chinese source label remains available below.

中文说明书原文Original Chinese source label

批准文号

国药准字H12020195

生产企业

天津天药药业股份有限公司(国产)

适应症

适合用于神经性皮炎、接触性皮炎、脂溢性皮炎以及慢性湿疹。

用法用量

1.外用。一日1-2次,取少量涂于患处,并轻揉片刻。 2.口服,成人开始剂量为一次0.75-3.00mg(1-4片),一日2-4次。维持量约一日0.75mg(1片),视病情而定。

不良反应

长期大量使用可致皮肤萎缩、毛细血管扩张、色素沉着以及继发感染。偶见过敏反应。

禁忌

1.对本品过敏者禁用。
2.患处已破溃、化脓或有明显渗出者禁用。
3.病毒感染者(如有疱疹、水痘)禁用。

注意事项

1.避免接触眼睛及其他黏膜部位。
2.孕妇、哺乳期妇女慎用。
3.不宜大面积、长期使用;用药1周后症状未缓解,请咨询医师。
4.如用药部位出现皮疹、瘙痒、红肿等,应停止用药,洗净,必要时向医师或药师咨询。
5.连续使用不能超过4周,面部、腋下、腹股沟及外阴等皮肤细薄处连续使用不能超过2周。
6.如并发细菌或真菌感染,请咨询医师处理。
7.当本品性状发生改变时禁用。
8.儿童必须在成人监护下使用。
9.请将此药品放在儿童不能接触的地方。

贮藏

遮光,密封保存。

规格

----

证据Evidence

  • 批准文号: 国药准字H12020195
  • rights: 本段为已核准说明书原文摘录(非改写、非AI摘要),非正式英文标签,亦不构成用药建议。

信息来源Source and scope

国家药品监督管理局(中国)药品注册数据。National Medical Products Administration (China) medicine-registration data.

范围:当前 MedicineGraph 注册记录及已记录的精确关系;非完整目录,亦不构成疗效等同主张,也不支持换用判断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence.